TRxADE Health Inc expected to post a loss of 12 cents a share - Earnings Preview

Scienture Holdings

22/10/2022 02:12

* TRxADE Health Inc  MEDS.OQ   MEDS.O  is expected to show a
rise
in quarterly revenue when it reports  results on October 24
(estimated). 
    * The Lutz Florida-based  company is expected to report  a
29.5% increase in revenue to $3.301 million from $2.55 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TRxADE Health Inc
is for
a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $3​, above​ its last closing price of $0.89. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.09       -0.08      -0.13     Missed  -62.5
 Mar. 31 2022  -0.11       -0.11      -0.12     Missed  -5.9
 Dec. 31 2021  -0.16       -0.15      -0.10     Beat    33.3​
 Sep. 30 2021  -0.13       -0.13      -0.16     Missed  -23.1
 ​​Jun.        -0.09       -0.09      -0.17     Missed  -96.1
 30 2021                                                
 Mar. 31 2021  -0.05       -0.05      -0.08     Missed  -71.4​
 Dec. 31 2020  0.01        0.01       -0.20     Missed  -2,100
 Sep. 30 2020  0.03        0.03       0.02      Missed  -33.3
 This summary was machine generated October 22 at 01:12 GMT.  All
figures in US dollars  unless otherwise stated